NF1: Clinical Trials

1 trial for NF1, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1

Follow NF1: new trials by email Literature Review of NF1 trials Research Report on NF1

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cabozantinib for Plexiform Neurofibromas (PN) in Subjects With NF1 in Children and Adults
Cabozantinib - NF1, Neurofibromatosis
Phase 2CompletedUniversity of Alabama at Birmingham452014-06-012023-05-24

Narrower conditions

Neurofibroma, Plexiform (1)  ·  Neurofibromatoses (1)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Heredodegenerative Disorders, Nervous System (1)  ·  Neoplasms (1)  ·  Neoplasms by Histologic Type (1)  ·  Neoplasms, Nerve Tissue (1)  ·  Neoplastic Syndromes, Hereditary (1)  ·  Nerve Sheath Neoplasms (1)  ·  Nervous System Diseases (1)  ·  Nervous System Neoplasms (1)  ·  Neurocutaneous Syndromes (1)  ·  Neurodegenerative Diseases (1)  ·  Neurofibroma (1)  ·  Neuromuscular Diseases (1)  ·  Peripheral Nervous System Diseases (1)

Interventions

cabozantinib (1)

Sponsors

University of Alabama at Birmingham (1)

Countries

United States (1)

Top investigators

Chie-Schin Shih, MD (1)

Results publications

PMID 32562630, PMID 33442015